Rockyview General Hospital is a large hospital. It is located in the city of Calgary, Alberta, Canada, on the shores of the Glenmore Reservoir and is administered by Alberta Health Services and formerly by the Calgary Health Region.

During the past decade, Rockyview General Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockyview General Hospital" #1 sponsor was "University of Calgary" with 12 trials, followed by "University of Alberta" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Hamilton Health Sciences Corporation" with 1 trials sponsored and "McMaster University" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockyview General Hospital" #1 collaborator was "Alberta Health services" with 5 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Alberta Innovates Health Solutions" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Apotex Inc." with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Rockyview General Hospital" are "COVID-19" (3 trials), "Acute Respiratory Distress Syndrome" (2 trials), "Breech Presentation" (2 trials), "Critical Illness" (2 trials) and "Hypoxemic Respiratory Failure" (2 trials). Many other conditions were trialed in "Rockyview General Hospital" in a lesser frequency.

Most popular intervention types in "Rockyview General Hospital" are "Drug" (7 trials), "Other" (6 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Convalescent plasma" (2 trials), "IV Nitroglycerin" (2 trials), "Normal saline" (2 trials) and "ARB + DMX-200" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockyview General Hospital" are 17 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Rockyview General Hospital". undefined are not yet recruiting, 9 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Rockyview General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rockyview General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".